MedTrace Logo

Early MRI Prediction of Crohns

NCT03340519 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 35

Last updated 2025-02-13

No results posted yet for this study

Summary

The investigators plan a prospective study designed to optimize and translate noncontrast, novel Magnetic Resonance Imaging (MRI) techniques for detecting and measuring intestinal inflammation as well as for allowing early prediction of response to medical therapy in small bowel Crohn's Disease (CD).

Conditions

  • Crohn Disease

Interventions

DEVICE

MR Imaging

Novel MR imaging will be performed to provide bowel anatomic and functional data

Sponsors & Collaborators

  • Children's Hospital Medical Center, Cincinnati

    lead OTHER

Principal Investigators

  • Jonathan R Dillman, MD, MSc · Children's Hospital Medical Center, Cincinnati

Eligibility

Min Age
11 Years
Max Age
25 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-12-17
Primary Completion
2021-10-25
Completion
2024-12-18
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03340519 on ClinicalTrials.gov